A panel of expert outside advisers to the U.S. Food and Drug Administration voted against approving COVID-19 booster shots for Americans, but may vote on a narrower approval for older adults later on Friday.
The panel voted overwhelmingly against approving boosters for Americans age 16 and older, potentially undermining the Biden administration's plan to roll out third shots of the Pfizer/BioNTech vaccine as soon as next week.
The FDA will take the panel's recommendation into consideration in making its decision on the boosters. But it can reject the advice as it did recently in approving Biogen Inc's controversial Alzheimer's drug